GeneFEAST: the pivotal, gene-centric step in functional enrichment analysis interpretation
Preprint
Taylor A. et al, (2023)
A Phase Ib/II study of IGF-neutralising antibody xentuzumab with enzalutamide in metastatic castration-resistant prostate cancer.
Journal article
Macaulay VM. et al, (2023), Br J Cancer
WNT5A-ROR2 axis mediates VEGF dependence of BRAF mutant melanoma.
Journal article
Coupe N. et al, (2022), Cell Oncol (Dordr)